title: Are they worth it? Executive compensation, company performance don't always relate at top hospital, post-acute and insurance companies.
abstract: Modern Healthcare's first comprehensive report on CEO pay at the top for-profit healthcare providers and insurers shows pay and stock performance aren't always linked. One exception is Norman Payson, left, who was tapped in 1998 to help turn around then-faltering Oxford Health Plans. He pulled in total direct compensation of $76 million last year, including $73 million in exercised stock options.
authors.forename: Vince
authors.initials: V
authors.lastname: Galloro
authors.forename: Laura B
authors.initials: LB
authors.lastname: Benko
mesh_terms: D000288:Administrative Personnel / Q000191:economics* / Q000592:standards; D016542:Chief Executive Officers, Hospital / Q000191:economics* / Q000592:standards; D003362:Cost-Benefit Analysis; D003625:Data Collection; D004649:Employee Incentive Plans / Q000706:statistics & numerical data*; D006777:Hospitals, Proprietary / Q000191:economics*; D007343:Insurance Carriers / Q000191:economics*; D007449:Investments / Q000191:economics; D012456:Salaries and Fringe Benefits / Q000706:statistics & numerical data*; D014481:United States